Structural characterization, including comprehensive analyses such as peptide mapping (including assessments of post-translational modifications), disulfide bridge analysis, glycan characterization, higher-order structure analysis (secondary and/or tertiary structure), charge isoform profiling and aggregation analyses, is the cornerstone of understanding your molecule's structure.
It is equally important to understand your molecule's intrinsic stability under extreme conditions. BioPharmaSpec's Forced Degradation Studies provide insights into potential degradation mechanisms and examine the robustness of your biopharmaceutical under stress conditions. These studies are integral to developing stability indicating methods that ensure product quality and consistency.
What is Forced Degradation?
Forced Degradation studies, also referred to as stress testing, deliberately expose samples to diverse stress conditions to simulate degradation pathways. These studies uncover precise degradation products and elucidate the chemical breakdown pathways under stress. This understanding is vital in biopharmaceutical development to ensure that active pharmaceutical ingredients (APIs) maintain their potency and safety throughout their lifecycle, guarding against potential efficacy loss or harmful side effects due to changes in the molecule affected by changes in the conditions it’s exposed to.
Why Should I Perform a Forced Degradation Study?
Forced Degradation studies provide crucial insights into how your product responds under extreme conditions potentially encountered throughout its lifecycle— such as those met during failures of shipment, packaging or other stages from initial manufacture right through to final handling at the patient location.
By simulating stressors like temperature fluctuations, pH variations and mechanical stresses, these studies help:
- Understand and mitigate potential degradation pathways which form product degradants such as aggregates (see figure below), ensuring product quality enhancements.
- Identify points of fragility of the product to external conditions
- Qualify analytical methods (per ICH Q2(R2) guidelines), confirming stability indicating method specificity and reliability ahead of tech transfer and full validation when appropriate.
- Assess and ultimately ensure similarity in degradation pathways with reference products, which is essential for biosimilar comparability assessments (per FDA and EMA guidelines).
Increasing Stress (e.g. temperature, pH)
Forced Degradation Testing at BioPharmaSpec
Forced degradation studies at BioPharmaSpec adhere to current industry best practices (as reported in this recent article), although specific methodologies can vary based on the nature of the sample and its intended use. Key methods to assess chemical stability include:
- Temperature Stress: Using elevated temperature to accelerate degradation pathways.
- Freeze-Thaw Cycles: Assessing the impact of temperature fluctuations.
- Mechanical Stress: Simulating conditions such as shaking and stirring.
- Photo Stability Testing: Evaluating light exposure effects per ICH guidelines.
- pH Stress: Testing at various pH levels to simulate different environments.
- Oxidative Stress: Identifying oxidative degradation pathways.
These approaches yield valuable insights into the structural integrity of biopharmaceuticals, aiding in process development and manufacturing decision-making.
Instrumentation and Analytical Procedures for Forced Degradation Studies
Our forced degradation studies employ a variety of advanced stability-indicating analytical methods and instruments to probe the structural integrity of drug substances under stress conditions investigating changes in post-translational modifications, disulfide bridges, glycan structure, higher-order structure (secondary and/or tertiary structure), physicochemical properties (such as charge isoforms) and aggregation. The analytical techniques utilized for these studies should not only aim to identify the nature of the modification(s) resulting from product stressing but they should also attempt to localize its/their positions within the protein chain.
An on-line MS peptide mapping analysis allows the identification of which amino acid(s) are modified in any particular peptide exhibiting a change in expected mass (as a result of the forced degradation conditions employed). For example, a peptide may be shown to be 1Da heavier in mass than predicted based on its amino acid sequence during a thermal stability study. Assessment of the high energy data derived fragmentation information from this peptide could show fragment ions consistent with an Aspartic acid residue in the sequence, where Asparagine has previously been shown to be present thus confirming the site of the deamidation, consistent with the 1Da observed mass increase of the peptide.
Peptide mapping: Digestion of the protein using enzymes breaks the protein down into peptides. The enzymes used are chosen based on the theoretical sequence of the protein and a knowledge of how the enzymes will theoretically digest the protein. In this way, an informed choice of enzymes(s) can be made that should result in the best peptide mapping analysis.
On-line LC/ES-MS analysis of a tryptic digest of a protein. A: The upper two panels show a section of the total ion chromatogram and the extracted ion chromatogram for a deamidated peptide of interest. B: The lower two panels show the low energy mass spectrum demonstrating the presence of the deamidated peptide and the higher energy MSe data shows the fragmentation of that peptide. Signals observed are not only consistent with the peptide, confirming its detection but also demonstrate that deamidation has occurred exclusively on the first of the two adjacent asparagine residues.
Planning a Forced Degradation study
for your molecule?
With decades of expertise in pharmaceutical analysis, BioPharmaSpec combines scientific expertise with cutting-edge technology to deliver reliable and insightful forced degradation testing. Whether you are in the early stages of development or nearing commercialization, our tailored studies are designed to meet the specific needs of your manufacturing decision making.
Talk to our scientists today to structure an efficient forced degradation study for your biopharmaceutical.